| OGM | Name: | methyl {4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate | Formula: | C10 H17 N3 O3 | SMILES: | COC(=O)NCCCCc1nc(CO)cn1 | InChi: | InChI=1S/C10H17N3O3/c1-16-10(15)11-5-3-2-4-9-12-6-8(7-14)13-9/h6,14H,2-5,7H2,1H3,(H,11,15)(H,12,13) | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | methyl {4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate |
|
| OGY | Name: | [2-(3-phenylpropyl)-1H-imidazol-4-yl]methanol | Formula: | C13 H16 N2 O | SMILES: | c1(ccccc1)CCCc2ncc(CO)n2 | InChi: | InChI=1S/C13H16N2O/c16-10-12-9-14-13(15-12)8-4-7-11-5-2-1-3-6-11/h1-3,5-6,9,16H,4,7-8,10H2,(H,14,15) | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | [2-(3-phenylpropyl)-1H-imidazol-4-yl]methanol |
|
| OH1 | Name: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}benzamide | Formula: | C15 H19 N3 O2 | SMILES: | C(NC(c1ccccc1)=O)CCCc2ncc(CO)n2 | InChi: | InChI=1S/C15H19N3O2/c19-11-13-10-17-14(18-13)8-4-5-9-16-15(20)12-6-2-1-3-7-12/h1-3,6-7,10,19H,4-5,8-9,11H2,(H,16,20)(H,17,18) | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}benzamide |
|
| OH4 | Name: | {2-[(3S)-3-methoxy-3-phenylpropyl]-1H-imidazol-4-yl}methanol | Formula: | C14 H18 N2 O2 | SMILES: | n2c(CCC(c1ccccc1)OC)nc(c2)CO | InChi: | InChI=1S/C14H18N2O2/c1-18-13(11-5-3-2-4-6-11)7-8-14-15-9-12(10-17)16-14/h2-6,9,13,17H,7-8,10H2,1H3,(H,15,16)/t13-/m0/s1 | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | {2-[(3S)-3-methoxy-3-phenylpropyl]-1H-imidazol-4-yl}methanol |
|
| OH7 | Name: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}acetamide | Formula: | C10 H17 N3 O2 | SMILES: | C(NC(C)=O)CCCc1ncc(CO)n1 | InChi: | InChI=1S/C10H17N3O2/c1-8(15)11-5-3-2-4-10-12-6-9(7-14)13-10/h6,14H,2-5,7H2,1H3,(H,11,15)(H,12,13) | Definition date: | 2019-06-24 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}acetamide |
|
| OHG | Name: | (2-methyl-1H-imidazol-4-yl)methanol | Formula: | C5 H8 N2 O | SMILES: | Cc1nc(cn1)CO | InChi: | InChI=1S/C5H8N2O/c1-4-6-2-5(3-8)7-4/h2,8H,3H2,1H3,(H,6,7) | Definition date: | 2019-06-25 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (2-methyl-1H-imidazol-4-yl)methanol |
|
| OHJ | Name: | (2-butyl-1H-imidazol-4-yl)methanol | Formula: | C8 H14 N2 O | SMILES: | C(c1cnc(CCCC)n1)O | InChi: | InChI=1S/C8H14N2O/c1-2-3-4-8-9-5-7(6-11)10-8/h5,11H,2-4,6H2,1H3,(H,9,10) | Definition date: | 2019-06-25 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | (2-butyl-1H-imidazol-4-yl)methanol |
|
| OWY | Name: | 4-[(R)-[(2S,5R)-4-benzyl-2,5-dimethylpiperazin-1-yl](3-hydroxyphenyl)methyl]-N,N-diethylbenzamide | Formula: | C31 H39 N3 O2 | SMILES: | CCN(CC)C(c1ccc(cc1)C(c2cccc(c2)O)N3C(CN(C(C3)C)Cc4ccccc4)C)=O | InChi: | InChI=1S/C31H39N3O2/c1-5-32(6-2)31(36)27-17-15-26(16-18-27)30(28-13-10-14-29(35)19-28)34-21-23(3)33(20-24(34)4)22-25-11-8-7-9-12-25/h7-19,23-24,30,35H,5-6,20-22H2,1-4H3/t23-,24+,30-/m1/s1 | Definition date: | 2019-07-15 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | 4-[(R)-[(2S,5R)-4-benzyl-2,5-dimethylpiperazin-1-yl](3-hydroxyphenyl)methyl]-N,N-diethylbenzamide |
|
| OHV | Name: | benzyl {4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate | Formula: | C16 H21 N3 O3 | SMILES: | C(CCCc1ncc(CO)n1)NC(=O)OCc2ccccc2 | InChi: | InChI=1S/C16H21N3O3/c20-11-14-10-18-15(19-14)8-4-5-9-17-16(21)22-12-13-6-2-1-3-7-13/h1-3,6-7,10,20H,4-5,8-9,11-12H2,(H,17,21)(H,18,19) | Definition date: | 2019-06-25 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | benzyl {4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate |
|
| OJG | Name: | N-{4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}-2-phenylacetamide | Formula: | C16 H21 N3 O2 | SMILES: | C(CNC(=O)Cc1ccccc1)CCc2ncc(CO)n2 | InChi: | InChI=1S/C16H21N3O2/c20-12-14-11-18-15(19-14)8-4-5-9-17-16(21)10-13-6-2-1-3-7-13/h1-3,6-7,11,20H,4-5,8-10,12H2,(H,17,21)(H,18,19) | Definition date: | 2019-06-26 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | N-{4-[5-(hydroxymethyl)-1H-imidazol-2-yl]butyl}-2-phenylacetamide |
|
| OJJ | Name: | methyl benzyl{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate | Formula: | C17 H23 N3 O3 | SMILES: | OCc2cnc(CCCCN(Cc1ccccc1)C(OC)=O)n2 | InChi: | InChI=1S/C17H23N3O3/c1-23-17(22)20(12-14-7-3-2-4-8-14)10-6-5-9-16-18-11-15(13-21)19-16/h2-4,7-8,11,21H,5-6,9-10,12-13H2,1H3,(H,18,19) | Definition date: | 2019-06-26 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | methyl benzyl{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}carbamate |
|
| OJM | Name: | ethyl 3-[4-(hydroxymethyl)-1H-imidazol-2-yl]propanoate | Formula: | C9 H14 N2 O3 | SMILES: | c1c(nc(CCC(=O)OCC)n1)CO | InChi: | InChI=1S/C9H14N2O3/c1-2-14-9(13)4-3-8-10-5-7(6-12)11-8/h5,12H,2-4,6H2,1H3,(H,10,11) | Definition date: | 2019-06-26 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | ethyl 3-[4-(hydroxymethyl)-1H-imidazol-2-yl]propanoate |
|
| OJP | Name: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}prop-2-enamide | Formula: | C11 H17 N3 O2 | SMILES: | c1c(nc(CCCCNC(/C=C)=O)n1)CO | InChi: | InChI=1S/C11H17N3O2/c1-2-11(16)12-6-4-3-5-10-13-7-9(8-15)14-10/h2,7,15H,1,3-6,8H2,(H,12,16)(H,13,14) | Definition date: | 2019-06-26 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | N-{4-[4-(hydroxymethyl)-1H-imidazol-2-yl]butyl}prop-2-enamide |
|
| OJY | Name: | 5-[5-(hydroxymethyl)-1H-imidazol-2-yl]-L-norvaline | Formula: | C9 H15 N3 O3 | SMILES: | C(c1nc(CO)cn1)CCC(C(=O)O)N | InChi: | InChI=1S/C9H15N3O3/c10-7(9(14)15)2-1-3-8-11-4-6(5-13)12-8/h4,7,13H,1-3,5,10H2,(H,11,12)(H,14,15)/t7-/m0/s1 | Definition date: | 2019-06-26 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | 5-[5-(hydroxymethyl)-1H-imidazol-2-yl]-L-norvaline |
|
| OK4 | Name: | N-acetyl-L-alanyl-5-[5-(hydroxymethyl)-1H-imidazol-2-yl]-L-norvalyl-L-valinamide | Formula: | C19 H32 N6 O5 | SMILES: | C(=O)(C)NC(C)C(=O)NC(C(=O)NC(C(N)=O)C(C)C)CCCc1nc(CO)cn1 | InChi: | InChI=1S/C19H32N6O5/c1-10(2)16(17(20)28)25-19(30)14(24-18(29)11(3)22-12(4)27)6-5-7-15-21-8-13(9-26)23-15/h8,10-11,14,16,26H,5-7,9H2,1-4H3,(H2,20,28)(H,21,23)(H,22,27)(H,24,29)(H,25,30)/t11-,14-,16-/m0/s1 | Definition date: | 2019-06-26 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | N-acetyl-L-alanyl-5-[5-(hydroxymethyl)-1H-imidazol-2-yl]-L-norvalyl-L-valinamide |
|
| M5D | Name: | 5-{(3R)-3-methyl-4-[(1R,2R)-2-methylcyclopropane-1-carbonyl]piperazin-1-yl}-3-(1-methyl-1H-pyrazol-4-yl)pyrazine-2-carbonitrile | Formula: | C19 H23 N7 O | SMILES: | c1(nc(cnc1C#N)N2CC(N(CC2)C(C3C(C3)C)=O)C)c4cnn(C)c4 | InChi: | InChI=1S/C19H23N7O/c1-12-6-15(12)19(27)26-5-4-25(10-13(26)2)17-9-21-16(7-20)18(23-17)14-8-22-24(3)11-14/h8-9,11-13,15H,4-6,10H2,1-3H3/t12-,13-,15-/m1/s1 | Definition date: | 2019-03-26 | Last modified: | 2019-12-06 | Release date: | 2019-12-11 | Identifier: | 5-{(3R)-3-methyl-4-[(1R,2R)-2-methylcyclopropane-1-carbonyl]piperazin-1-yl}-3-(1-methyl-1H-pyrazol-4-yl)pyrazine-2-carbonitrile |
|
| RSP | Name: | 4-amino-1-(5-O-phosphono-beta-D-ribofuranosyl)pyrimidine-2(1H)-thione | Formula: | C9 H14 N3 O7 P S | SMILES: | NC1=NC(=S)N(C=C1)[CH]2O[CH](CO[P](O)(O)=O)[CH](O)[CH]2O | InChi: | InChI=1S/C9H14N3O7PS/c10-5-1-2-12(9(21)11-5)8-7(14)6(13)4(19-8)3-18-20(15,16)17/h1-2,4,6-8,13-14H,3H2,(H2,10,11,21)(H2,15,16,17)/t4-,6-,7-,8-/m1/s1 | Definition date: | 2010-01-11 | Last modified: | 2019-12-05 | Identifier: | [(2R,3S,4R,5R)-5-(4-azanyl-2-sulfanylidene-pyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate |
|
| Q9J | Name: | (5S,6S,8R)-2-(1,3-benzothiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8-methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide | Formula: | C17 H17 N5 O2 S | SMILES: | C5C4Cn3c(c(C(N)=O)c(c2cc1c(scn1)cc2)n3)NC(C4)C5O | InChi: | InChI=1S/C17H17N5O2S/c18-16(24)14-15(9-1-2-13-11(5-9)19-7-25-13)21-22-6-8-3-10(12(23)4-8)20-17(14)22/h1-2,5,7-8,10,12,20,23H,3-4,6H2,(H2,18,24)/t8-,10+,12+/m1/s1 | Definition date: | 2019-10-07 | Last modified: | 2019-11-29 | Release date: | 2019-12-04 | Identifier: | (5S,6S,8R)-2-(1,3-benzothiazol-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8-methanopyrazolo[1,5-a][1,3]diazocine-3-carboxamide |
|
| LFE | Name: | ~{N}-[(5~{S},7~{R},11~{S},23~{S})-11-~{tert}-butyl-34-(4-methyl-1,3-thiazol-5-yl)-7-oxidanyl-4,10,13-tris(oxidanylidene)-15,18,21,25,28,31-hexaoxa-3,9,12-triazatricyclo[30.4.0.0^{5,9}]hexatriaconta-1(32),33,35-trien-23-yl]-2-[(7~{S},9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,10,12-tetraen-9-yl]ethanamide | Formula: | C54 H70 Cl N9 O11 S2 | SMILES: | Cc1sc2n3c(C)nnc3[CH](CC(=O)N[CH]4COCCOCCOCC(=O)N[CH](C(=O)N5C[CH](O)C[CH]5C(=O)NCc6ccc(cc6OCCOCCOC4)c7scnc7C)C(C)(C)C)N[CH](c8ccc(Cl)cc8)c2c1C | InChi: | InChI=1S/C54H70ClN9O11S2/c1-31-33(3)77-53-46(31)47(35-10-12-38(55)13-11-35)59-41(50-62-61-34(4)64(50)53)24-44(66)58-39-27-72-17-14-70-16-19-74-29-45(67)60-49(54(5,6)7)52(69)63-26-40(65)23-42(63)51(68)56-25-37-9-8-36(48-32(2)57-30-76-48)22-43(37)75-21-20-71-15-18-73-28-39/h8-13,22,30,39-42,47,49,59,65H,14-21,23-29H2,1-7H3,(H,56,68)(H,58,66)(H,60,67)/t39-,40+,41-,42-,47-,49+/m0/s1 | Definition date: | 2019-08-12 | Last modified: | 2019-11-29 | Release date: | 2019-12-04 | Identifier: | ~{N}-[(5~{S},7~{R},11~{S},23~{S})-11-~{tert}-butyl-34-(4-methyl-1,3-thiazol-5-yl)-7-oxidanyl-4,10,13-tris(oxidanylidene)-15,18,21,25,28,31-hexaoxa-3,9,12-triazatricyclo[30.4.0.0^{5,9}]hexatriaconta-1(32),33,35-trien-23-yl]-2-[(7~{S},9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,10,12-tetraen-9-yl]ethanamide |
|
| JV1 | Name: | (~{E})-3-(1,3-benzodioxol-5-yl)-1-(3-nitrophenyl)prop-2-en-1-one | Formula: | C16 H11 N O5 | SMILES: | [O-][N+](=O)c1cccc(c1)C(=O)C=Cc2ccc3OCOc3c2 | InChi: | InChI=1S/C16H11NO5/c18-14(12-2-1-3-13(9-12)17(19)20)6-4-11-5-7-15-16(8-11)22-10-21-15/h1-9H,10H2/b6-4+ | Definition date: | 2019-09-09 | Last modified: | 2019-11-29 | Release date: | 2019-12-04 | Identifier: | (~{E})-3-(1,3-benzodioxol-5-yl)-1-(3-nitrophenyl)prop-2-en-1-one |
|
| Q0M | Name: | 3-{[(5-bromo-3-chloro-2-hydroxyphenyl)sulfonyl]amino}-5-(1-cyanocyclobutyl)-2-hydroxy-N-methylbenzamide | Formula: | C19 H17 Br Cl N3 O5 S | SMILES: | c3(NS(c1cc(cc(c1O)Cl)Br)(=O)=O)c(c(C(NC)=O)cc(C2(CCC2)C#N)c3)O | InChi: | InChI=1S/C19H17BrClN3O5S/c1-23-18(27)12-5-10(19(9-22)3-2-4-19)6-14(16(12)25)24-30(28,29)15-8-11(20)7-13(21)17(15)26/h5-8,24-26H,2-4H2,1H3,(H,23,27) | Definition date: | 2019-09-03 | Last modified: | 2019-11-29 | Release date: | 2019-12-04 | Identifier: | 3-{[(5-bromo-3-chloro-2-hydroxyphenyl)sulfonyl]amino}-5-(1-cyanocyclobutyl)-2-hydroxy-N-methylbenzamide |
|
| Q0S | Name: | 5-bromo-2-hydroxy-N-[3-(methylsulfonyl)-5-(pentafluoro-lambda~6~-sulfanyl)phenyl]benzene-1-sulfonamide | Formula: | C13 H11 Br F5 N O5 S3 | SMILES: | c1(cc(ccc1O)Br)S(Nc2cc(S(F)(F)(F)(F)F)cc(c2)S(C)(=O)=O)(=O)=O | InChi: | InChI=1S/C13H11BrF5NO5S3/c1-26(22,23)10-5-9(6-11(7-10)28(15,16,17,18)19)20-27(24,25)13-4-8(14)2-3-12(13)21/h2-7,20-21H,1H3 | Definition date: | 2019-09-03 | Last modified: | 2019-11-29 | Release date: | 2019-12-04 | Identifier: | 5-bromo-2-hydroxy-N-[3-(methylsulfonyl)-5-(pentafluoro-lambda~6~-sulfanyl)phenyl]benzene-1-sulfonamide |
|
| Q0Y | Name: | 5-bromo-N-(5-chloro-2-hydroxyphenyl)-2-methoxybenzene-1-sulfonamide | Formula: | C13 H11 Br Cl N O4 S | SMILES: | c1c(Br)ccc(c1S(Nc2cc(ccc2O)Cl)(=O)=O)OC | InChi: | InChI=1S/C13H11BrClNO4S/c1-20-12-5-2-8(14)6-13(12)21(18,19)16-10-7-9(15)3-4-11(10)17/h2-7,16-17H,1H3 | Definition date: | 2019-09-03 | Last modified: | 2019-11-29 | Release date: | 2019-12-04 | Identifier: | 5-bromo-N-(5-chloro-2-hydroxyphenyl)-2-methoxybenzene-1-sulfonamide |
|
| Q1G | Name: | 5-bromo-N-[5-(1-cyanocyclobutyl)-2-hydroxyphenyl]-2-hydroxybenzene-1-sulfonamide | Formula: | C17 H15 Br N2 O4 S | SMILES: | c1(c(ccc(c1)Br)O)S(Nc3cc(C2(CCC2)C#N)ccc3O)(=O)=O | InChi: | InChI=1S/C17H15BrN2O4S/c18-12-3-5-15(22)16(9-12)25(23,24)20-13-8-11(2-4-14(13)21)17(10-19)6-1-7-17/h2-5,8-9,20-22H,1,6-7H2 | Definition date: | 2019-09-06 | Last modified: | 2019-11-29 | Release date: | 2019-12-04 | Identifier: | 5-bromo-N-[5-(1-cyanocyclobutyl)-2-hydroxyphenyl]-2-hydroxybenzene-1-sulfonamide |
|
| Q1J | Name: | 5-bromo-N-(4-hydroxy[1,1'-biphenyl]-3-yl)-2-methoxybenzene-1-sulfonamide | Formula: | C19 H16 Br N O4 S | SMILES: | c1(ccc(c(c1)S(Nc3c(ccc(c2ccccc2)c3)O)(=O)=O)OC)Br | InChi: | InChI=1S/C19H16BrNO4S/c1-25-18-10-8-15(20)12-19(18)26(23,24)21-16-11-14(7-9-17(16)22)13-5-3-2-4-6-13/h2-12,21-22H,1H3 | Definition date: | 2019-09-06 | Last modified: | 2019-11-29 | Release date: | 2019-12-04 | Identifier: | 5-bromo-N-(4-hydroxy[1,1'-biphenyl]-3-yl)-2-methoxybenzene-1-sulfonamide |
|